Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
LPL Financial Holdings Inc is a capital markets business based in the US. LPL Financial shares (LPLA) are listed on the NASDAQ and all prices are listed in US Dollars. LPL Financial employs 5,344 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$155.64|
|52-week range||$74.54 - $159.20|
|50-day moving average||$146.04|
|200-day moving average||$143.66|
|Wall St. target price||$188.88|
|Dividend yield||$1 (0.65%)|
|Earnings per share (TTM)||$5.72|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-09-17)||6.01%|
|1 month (2021-08-26)||5.53%|
|3 months (2021-06-25)||9.17%|
|6 months (2021-03-26)||9.83%|
|1 year (2020-09-25)||106.69%|
|2 years (2019-09-26)||87.90%|
|3 years (2018-09-26)||139.19%|
|5 years (2016-09-26)||436.50%|
Valuing LPL Financial stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of LPL Financial's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
LPL Financial's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 27x. In other words, LPL Financial shares trade at around 27x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).
LPL Financial's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.1195. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into LPL Financial's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
LPL Financial's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $955.6 million.
The EBITDA is a measure of a LPL Financial's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$6.6 billion|
|Operating margin TTM||11.37%|
|Gross profit TTM||$1.5 billion|
|Return on assets TTM||7.2%|
|Return on equity TTM||34.86%|
|Market capitalisation||$12.5 billion|
TTM: trailing 12 months
There are currently 1.1 million LPL Financial shares held short by investors – that's known as LPL Financial's "short interest". This figure is 8.6% down from 1.2 million last month.
There are a few different ways that this level of interest in shorting LPL Financial shares can be evaluated.
LPL Financial's "short interest ratio" (SIR) is the quantity of LPL Financial shares currently shorted divided by the average quantity of LPL Financial shares traded daily (recently around 376649.12280702). LPL Financial's SIR currently stands at 2.85. In other words for every 100,000 LPL Financial shares traded daily on the market, roughly 2850 shares are currently held short.
However LPL Financial's short interest can also be evaluated against the total number of LPL Financial shares, or, against the total number of tradable LPL Financial shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case LPL Financial's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 LPL Financial shares in existence, roughly 10 shares are currently held short) or 0.0135% of the tradable shares (for every 100,000 tradable LPL Financial shares, roughly 14 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against LPL Financial.
Find out more about how you can short LPL Financial stock.
Dividend payout ratio: 17.48% of net profits
Recently LPL Financial has paid out, on average, around 17.48% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.65% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), LPL Financial shareholders could enjoy a 0.65% return on their shares, in the form of dividend payments. In LPL Financial's case, that would currently equate to about $1 per share.
While LPL Financial's payout ratio might seem low, this can signify that LPL Financial is investing more in its future growth.
LPL Financial's most recent dividend payout was on 26 August 2021. The latest dividend was paid out to all shareholders who bought their shares by 11 August 2021 (the "ex-dividend date").
Over the last 12 months, LPL Financial's shares have ranged in value from as little as $74.5376 up to $159.1997. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while LPL Financial's is 1.2276. This would suggest that LPL Financial's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
LPL Financial Holdings Inc. , together with its subsidiaries, provides an integrated platform of brokerage and investment advisory services to independent financial advisors and financial advisors at financial institutions in the United States. Its brokerage offerings include variable and fixed annuities, mutual funds, equities, retirement and education savings plans, fixed income, and insurance, as well as alternative investments, such as non-traded real estate investment trusts and business development companies. The company also provides advisory platforms that provide access to mutual funds, exchange-traded funds, stocks, bonds, certain option strategies, unit investment trusts, and institutional money managers and no-load multi-manager variable annuities. In addition, it offers money market programs; and retirement solutions for commission-and fee-based services that allow advisors to provide brokerage services, consultation, and advice to retirement plan sponsors. Further, the company provides other services comprising tools and services that enable advisors to maintain and grow their practices; trust, investment management oversight, and custodial services to trusts for estates and families, as well as insurance brokerage general agency services; and technology products, such as proposal generation, investment analytics, and portfolio modeling. The company was formerly known as LPL Investment Holdings Inc.
Everything we know about the Enfusion IPO, plus information on how to buy in.
Everything we know about the Intuity Medical IPO, plus information on how to buy in.
Everything we know about the Pyxis Oncology IPO, plus information on how to buy in.
Everything we know about the AEON Biopharma IPO, plus information on how to buy in.
Everything we know about the IHS Holding Ltd IPO, plus information on how to buy in.
Everything we know about the BT Brands IPO, plus information on how to buy in.
Everything we know about the Immix IPO, plus information on how to buy in.
Everything we know about the Keter Group SA IPO, plus information on how to buy in.
Everything we know about the Theseus Pharmaceuticals IPO, plus information on how to buy in.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Sep. 20, 2021
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.